NO20044903L - Anvendelse av nye etonogestrel estere - Google Patents
Anvendelse av nye etonogestrel estereInfo
- Publication number
- NO20044903L NO20044903L NO20044903A NO20044903A NO20044903L NO 20044903 L NO20044903 L NO 20044903L NO 20044903 A NO20044903 A NO 20044903A NO 20044903 A NO20044903 A NO 20044903A NO 20044903 L NO20044903 L NO 20044903L
- Authority
- NO
- Norway
- Prior art keywords
- new
- etonogestrel esters
- contraceptive
- esters
- new etonogestrel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pregnancy & Childbirth (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02077118 | 2002-05-30 | ||
PCT/EP2003/050188 WO2003101374A2 (en) | 2002-05-30 | 2003-05-22 | Use of new etonogestrel esters |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20044903L true NO20044903L (no) | 2005-02-25 |
Family
ID=29595013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20044903A NO20044903L (no) | 2002-05-30 | 2004-11-10 | Anvendelse av nye etonogestrel estere |
Country Status (27)
Country | Link |
---|---|
US (1) | US20050222114A1 (xx) |
EP (1) | EP1513588B1 (xx) |
JP (1) | JP2005532336A (xx) |
KR (1) | KR20050005507A (xx) |
CN (1) | CN1655848A (xx) |
AR (1) | AR040129A1 (xx) |
AT (1) | ATE394140T1 (xx) |
AU (1) | AU2003246740B2 (xx) |
BR (1) | BR0311248A (xx) |
CA (1) | CA2487293A1 (xx) |
DE (1) | DE60320786D1 (xx) |
ES (1) | ES2305498T3 (xx) |
HK (1) | HK1072568A1 (xx) |
HR (1) | HRP20041127A2 (xx) |
IL (1) | IL165125A0 (xx) |
IS (1) | IS7537A (xx) |
MX (1) | MXPA04011798A (xx) |
NO (1) | NO20044903L (xx) |
NZ (1) | NZ536618A (xx) |
PE (1) | PE20040042A1 (xx) |
PL (1) | PL373295A1 (xx) |
RS (1) | RS101004A (xx) |
RU (1) | RU2322986C2 (xx) |
TW (1) | TW200400041A (xx) |
UA (1) | UA80703C2 (xx) |
WO (1) | WO2003101374A2 (xx) |
ZA (1) | ZA200409498B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200403065A (en) * | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
US20130123523A1 (en) * | 2011-11-10 | 2013-05-16 | Klaus Nickisch | Methods for the preparation of etonogestrel and desogestrel |
DE102012211511A1 (de) * | 2012-07-03 | 2014-01-09 | Siemens Aktiengesellschaft | Bestimmung der Eignung einer Ressource |
EP3697421B1 (en) * | 2017-10-19 | 2024-04-17 | Evestra, Inc. | Longer-acting progestin prodrug contraceptives |
CN111057120B (zh) * | 2019-12-27 | 2021-04-27 | 苏州翔实医药发展有限公司 | 一种依托孕烯衍生物a及其制备方法和用途 |
EP4164743A2 (en) * | 2020-06-11 | 2023-04-19 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Monomeric and oligomeric compound embodiments as contraceptives and therapies and methods of making and using the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4227989A1 (de) * | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
DE4240806A1 (de) * | 1992-12-01 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 14alpha,17alpha-Ethanoestra-1,3,5(10)-trien-3,17beta-diol |
JPH07101884A (ja) * | 1993-10-01 | 1995-04-18 | Sanei Gen F F I Inc | 水溶性ヘミセルロースを含有する製剤 |
AU692504B2 (en) * | 1993-12-27 | 1998-06-11 | Akzo Nobel N.V. | Percutaneously absorbable preparation |
WO1997003709A1 (de) * | 1995-07-17 | 1997-02-06 | Schering Aktiengesellschaft | Mittel zur transdermalen applikation enthaltend ester des 3-ketodegestrel |
PT1087986E (pt) * | 1998-06-19 | 2002-08-30 | Akzo Nobel Nv | Undecanoato de 7alfa-metil-19-nortestosterona com actividade androgenica |
AU4513099A (en) * | 1998-06-19 | 2000-01-10 | Akzo Nobel N.V. | Cycloalkyl-carboxylic acid esters of 7.alpha.methyl-estr-4-en-3-one 17.beta.-ol (19-nor 7.alpha.-methyltestosterone) |
US6180682B1 (en) * | 1999-01-26 | 2001-01-30 | Virgil A. Place | Buccal drug delivery system for use in male contraception |
TW200403065A (en) * | 2002-05-30 | 2004-03-01 | Akzo Nobel Nv | New etonogestrel esters |
-
2003
- 2003-05-19 TW TW092113492A patent/TW200400041A/zh unknown
- 2003-05-22 MX MXPA04011798A patent/MXPA04011798A/es unknown
- 2003-05-22 UA UA20041109285A patent/UA80703C2/uk unknown
- 2003-05-22 DE DE60320786T patent/DE60320786D1/de not_active Expired - Fee Related
- 2003-05-22 US US10/517,362 patent/US20050222114A1/en not_active Abandoned
- 2003-05-22 KR KR10-2004-7019327A patent/KR20050005507A/ko not_active Application Discontinuation
- 2003-05-22 BR BR0311248-9A patent/BR0311248A/pt not_active IP Right Cessation
- 2003-05-22 CA CA002487293A patent/CA2487293A1/en not_active Abandoned
- 2003-05-22 JP JP2004508732A patent/JP2005532336A/ja not_active Withdrawn
- 2003-05-22 WO PCT/EP2003/050188 patent/WO2003101374A2/en active IP Right Grant
- 2003-05-22 CN CNA038123657A patent/CN1655848A/zh active Pending
- 2003-05-22 NZ NZ536618A patent/NZ536618A/en unknown
- 2003-05-22 EP EP03755980A patent/EP1513588B1/en not_active Expired - Lifetime
- 2003-05-22 AT AT03755980T patent/ATE394140T1/de not_active IP Right Cessation
- 2003-05-22 ES ES03755980T patent/ES2305498T3/es not_active Expired - Lifetime
- 2003-05-22 AU AU2003246740A patent/AU2003246740B2/en not_active Ceased
- 2003-05-22 RS YU101004A patent/RS101004A/sr unknown
- 2003-05-22 RU RU2004138809/15A patent/RU2322986C2/ru active
- 2003-05-22 PL PL03373295A patent/PL373295A1/xx not_active Application Discontinuation
- 2003-05-26 PE PE2003000508A patent/PE20040042A1/es not_active Application Discontinuation
- 2003-05-28 AR ARP030101858A patent/AR040129A1/es unknown
-
2004
- 2004-11-09 IL IL16512504A patent/IL165125A0/xx unknown
- 2004-11-10 NO NO20044903A patent/NO20044903L/no not_active Application Discontinuation
- 2004-11-18 IS IS7537A patent/IS7537A/is unknown
- 2004-11-24 ZA ZA200409498A patent/ZA200409498B/xx unknown
- 2004-11-25 HR HR20041127A patent/HRP20041127A2/hr not_active Application Discontinuation
-
2005
- 2005-06-28 HK HK05105351A patent/HK1072568A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
UA80703C2 (en) | 2007-10-25 |
US20050222114A1 (en) | 2005-10-06 |
PE20040042A1 (es) | 2004-01-31 |
IL165125A0 (en) | 2005-12-18 |
WO2003101374A3 (en) | 2004-02-26 |
AR040129A1 (es) | 2005-03-16 |
IS7537A (is) | 2004-11-18 |
BR0311248A (pt) | 2005-03-15 |
WO2003101374A2 (en) | 2003-12-11 |
MXPA04011798A (es) | 2005-03-31 |
CA2487293A1 (en) | 2003-12-11 |
PL373295A1 (en) | 2005-08-22 |
AU2003246740A1 (en) | 2003-12-19 |
NZ536618A (en) | 2007-06-29 |
RU2322986C2 (ru) | 2008-04-27 |
RS101004A (xx) | 2006-10-27 |
TW200400041A (en) | 2004-01-01 |
DE60320786D1 (de) | 2008-06-19 |
HRP20041127A2 (en) | 2005-02-28 |
EP1513588B1 (en) | 2008-05-07 |
CN1655848A (zh) | 2005-08-17 |
HK1072568A1 (en) | 2005-09-02 |
RU2004138809A (ru) | 2005-06-10 |
KR20050005507A (ko) | 2005-01-13 |
JP2005532336A (ja) | 2005-10-27 |
ZA200409498B (en) | 2006-05-31 |
EP1513588A2 (en) | 2005-03-16 |
ES2305498T3 (es) | 2008-11-01 |
ATE394140T1 (de) | 2008-05-15 |
AU2003246740B2 (en) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1490463T3 (da) | Lav-transfedtsyrer til konfekture og fedtsammensætninger til bagning | |
DE60029956D1 (de) | Amid-substituierte Imidazochinoline | |
NO20035632L (no) | Selv-emulgerende formuleringer av kolesterylester-overforingsproteininhibitorer | |
FI20021947A (fi) | Menetelmä triglyseridien rasvahappoketjukoostumuksen säätämiseksi sekä menetelmän käyttö | |
EE200300052A (et) | Kolesterüülestri ülekandevalgu inhibiitorite farmatseutilised kompositsioonid | |
IS5976A (is) | Bensóheteróhringir og notkun theirra sem MEK-hemlar | |
NO20052229D0 (no) | Basiske estere av fettalkoholer og deres anvendelse som antiinfammatoriske eller immunstimulerende midler | |
NO20041872L (no) | Esterforbindelser og medisinsk anvendelse derav | |
CY1107641T1 (el) | Φαρμακευτικη συνθεση περιλαμβανουσα αναστολεα λιπασης και μονο-εστερα λιπαρου οξεος με σακχαροζη | |
DK1292561T3 (da) | Fremgangsmåde til fremstillingen af cyclopropylcarboxylsyreestere og -derivater | |
CY2009001I2 (el) | Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης | |
IS2421B (is) | Nýir etónógestrel esterar | |
NO20044903L (no) | Anvendelse av nye etonogestrel estere | |
DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
IL155174A0 (en) | Methods and compositions for the treatment of inflammatory diseases | |
DE60317214D1 (de) | Kristallines gamma-lacton der17beta-hydroxy-7alpha-(5'-methyl-2'-furyl)-pregna-4,9(11)-dien-3-one-21-carbonsäure | |
NO20014444L (no) | Topisk appliserbare bioadhesive preparater samt fremgangsmåter for anvendelse og fremstilling derav | |
PT841933E (pt) | Composicoes do inibidor bowman-birk para tratamento de doencas inflamatorias | |
NO20032054D0 (no) | Fettsyreanaloger for behandling av inflammatoriske lidelser og autoimmune forstyrrelser | |
AU2003291634A1 (en) | Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory | |
DK1496884T3 (da) | Blanding af et antithrombotisk middel med aspirin og anvendelse heraf til behandling af atherothrombotiske sygdomme | |
ITMI922657A0 (it) | Composizione terapeutica per uso rettale a base di flunisolide e/o deirelativi esteri per il trattamento di disordini intestinali a carattere infiammatorio | |
ITMI991737A0 (it) | Composizioni a rilascio controllato di paracetamolo | |
NO20031080L (no) | Fettsyreanaloger for behandling av proliferative sykdommer | |
FR2818982B1 (fr) | Inhibiteur specifique du systeme ubiquitine-proteasome et applications therapeutiques correspondantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |